no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acknowledgement of reviewers 2020
|
|
|
|
87 |
3 |
p. 443-446 |
article |
2 |
Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer
|
Liu, Shuang |
|
|
87 |
3 |
p. 415-423 |
article |
3 |
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors
|
Park, Haeseong |
|
|
87 |
3 |
p. 337-347 |
article |
4 |
A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteers
|
Chen, Rui |
|
|
87 |
3 |
p. 387-396 |
article |
5 |
A Phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX02 to reference CN- and EU-sourced trastuzumab in healthy subjects
|
Zhu, X. |
|
|
87 |
3 |
p. 349-359 |
article |
6 |
BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case series
|
Butt, Sabeeh-ur-Rehman |
|
|
87 |
3 |
p. 437-441 |
article |
7 |
Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia
|
Al-Sheikh, Abrar |
|
|
87 |
3 |
p. 379-385 |
article |
8 |
FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study
|
Umemoto, Kumiko |
|
|
87 |
3 |
p. 397-404 |
article |
9 |
FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway
|
Liu, Ya-Kun |
|
|
87 |
3 |
p. 405-414 |
article |
10 |
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed
|
Meemanage, Madusha |
|
|
87 |
3 |
p. 361-377 |
article |
11 |
Involvement of cytochrome P450 enzymes in inflammation and cancer: a review
|
Stipp, Maria Carolina |
|
|
87 |
3 |
p. 295-309 |
article |
12 |
Irinotecan-induced intestinal mucositis in mice: a histopathological study
|
Boeing, Thaise |
|
|
87 |
3 |
p. 327-336 |
article |
13 |
Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation
|
Shan, Chuan-Kun |
|
|
87 |
3 |
p. 425-436 |
article |
14 |
The use of zebrafish model in prostate cancer therapeutic development and discovery
|
Amawi, Haneen |
|
|
87 |
3 |
p. 311-325 |
article |